Genetic variants of interleukin-1RN and interleukin-1β genes and risk of cervical cancer

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 115, Issue 5, 2008, Pages 633-638

  Singh, H ^a   Sachan, R ^b   Goel, H ^a   Mittal, B ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Cervical cancer; Genetic susceptibility; Interleukin 1 receptor antagonist; Polymorphism

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA;

ADULT; ARTICLE; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; DNA POLYMORPHISM; ETHNICITY; FEMALE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY;

CASE-CONTROL STUDIES; DNA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; INTERLEUKIN-1BETA; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 40549105477     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2007.01655.x     Document Type: Article

References (27)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001 94 : 153 6.
2. Sankaranarayanan R, Nene BM, Dinshaw K, Rajkumar R, Shastri S, Wesley R, et al. Early detection of cervical cancer with visual inspection methods: a summary of completed and on-going studies in India. Salud Publica Mex 2003 45 : 274 82.
3. Farzaneh F, Roberts S, Mandal D, Ollier B, Winters U, Kitchener HC, et al. The IL-10 -1082G polymorphism is associated with clearance of HPV infection. BJOG 2006 113 : 961 4.
4. Wallin KL, Wiklund F, Angstrom T, Bergman F, Stendahl U, Wadell G, et al. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 1999 341 : 1633 8.
5. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993 85 : 958 64.
6. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996 87 : 2095 147.
7. Arend WP, Malyak M, Guthridge CJ, Gabay C. Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol 1998 16 : 27 55.
8. Iizuka N, Hazama S, Hirose K, Abe T, Tokuda N, Fukumoto T, et al. Interleukin-1 receptor antagonist mRNA expression and the progression of gastric carcinoma. Cancer Lett 1999 142 : 179 84.
9. Eisenberg SP, Brewer MT, Verderber E, Heimdal P, Brandhuber BJ, Thompson RC. Interleukin 1 receptor antagonist is a member of the interleukin 1 gene family: evolution of a cytokine control mechanism. Proc Natl Acad Sci U S A 1991 88 : 5232 6.
10. Witkin SS, Gerber S, Ledger WJ. Influence of interleukin-1 receptor antagonist gene polymorphism on disease. Clin Infect Dis 2002 34 : 204 9.
11. Palmer LJ, Cardon LR. Shaking the tree: mapping complex disease genes with linkage disequilibrium. Lancet 2005 366 : 1223 34.
12. Nicklin MJ, Weith A, Duff GW. A physical map of the region encompassing the human interleukin-1α, interleukin-1β, and interleukin-1 receptor antagonist genes. Genomics 1994 19 : 382 4.
13. Dinarello C. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int Rev Immunol 1998 16 : 457 99.
14. Tarlow JK, Blakemore AIF, Lennard A, Solari R, Hughes HN, Steinkasserer A, et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993 91 : 403 4.
15. Marth C, Zeimet AG, Herold M, Brumm C, Windbichler G, Muller-Holzner E, et al. Different effects of interferons, interleukin-1ß and tumor necrosis factor- in normal (OSE) and malignant human ovarian epithelial cells. Int J Cancer 1996 67 : 826 30.
16. Mustea A, Sehouli J, Konsgen D, Stengel D, Sofroni D, Lichtenegger W. Interleukin 1 receptor antagonist (IL-1RA) polymorphism in women with cervical cancer. Anticancer Res 2003 23 : 1099 102.
17. Sehouli J, Mustea A. Interleukin-1 receptor antagonist gene polymorphism and cancer. Clin Infect Dis 2002 34 : 1535 6.
18. Di Giovine FS, Takhsh E, Blakemore AI, Duff GW. Single base polymorphism at -511 in the human interleukin-1β gene (IL1β). Hum Mol Genet 1992 1 : 450.
19. Pociot F, Molvig J, Wogensen L, Worsaae H, Nerup J. A Taq polymorphism in the human interleukin-1β (IL-1β) gene correlates with IL-1β secretion in vitro. Eur J Clin Invest 1992 22 : 396 402.
20. Kang S, Kim JW, Park NH, Song YS, Park SY, Kang SB, et al. Interleukin-1 beta-511 polymorphism and risk of cervical cancer. J Korean Med Sci 2007 22 : 110 13.
21. Achyut BR, Srivastava A, Bhattacharya S, Mittal B. Genetic association of interleukin-1beta (-511C/T) and interleukin-1 receptor antagonist (86 bp repeat) polymorphisms with Type 2 diabetes mellitus in North Indians. Clin Chim Acta 2007 377 : 163 9.
22. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988 16 : 1215.
23. Cox A, Camp NJ, Nicklin MJ, di Giovine FS, Duff GW. An analysis of linkage disequilibrium in the interleukin-1 gene cluster, using a novel grouping method for multiallelic markers. Am J Hum Genet 1998 62 : 1180 8.
24. Hurme M, Santtila S. IL-1 receptor antagonist (IL-1Ra) plasma levels are coordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol 1998 28 : 2598 602.
25. Parks CG, Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS, et al. Systemic lupus erythematosus and genetic variation in the interleukin 1 gene cluster: population based study in the southeastern United States. Ann Rheum Dis 2004 63 : 91 4.
26. Hutyrova B, Pantellidis P, Drabek. JIÍ, Rkova M, Kolek VZ, Lenhart K, et al. Interleukin-1 Gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002 165 : 148 51.
27. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000 404 : 398 402.